Liraglutide

Product Overview

• Full Name: Liraglutide
• Classification: Long-acting acylated GLP‑1 Receptor Agonist
• Molecular Formula:C₁₇₂H₂₆₅N₄₃O₅₁
• Molecular Weight: ~3751.2 Da
• CAS Number: 204656-20-2
• Core Mechanism
  1. Glucose-dependent insulin release: Only boost insulin secretion when blood sugar rises, eliminate severe hypoglycemia risk
  2. Suppress excess post-meal glucagon to reduce liver glucose output, stabilize fasting blood glucose
  3. Slow gastric emptying to prolong long-lasting satiety, cut cravings for sugar, refined carbs and midnight snacks
  4. Target hypothalamic satiety center to lower spontaneous daily calorie intake naturally
  5. C16 fatty acid side chain modification binds albumin to resist DPP‑4 degradation, half-life ~13 hours for stable once-daily subcutaneous injection
• Purity: ≥ 99% verified, Endotoxin < 1 EU/mg

Product Attributes